XETR
2HRA
, Last price
Name
H&R GmbH & Co KgaA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
H&R GmbH & Co. KGaA is a German enterprise specializing in the production and distribution of chemical-pharmaceutical raw materials and precision plastic components, manufactured through injection molding. The company's operations are structured into three primary segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining division is responsible for manufacturing and supplying a diverse array of refined products, including paraffins, white oils, plasticizers, base oils, lubricants, and other specialized crude oil derivatives, as well as feedstocks and bunker fuels. Concurrently, the ChemPharm Sales segment focuses on the processing and commercialization of products such as plasticizers, wax emulsions, paraffins, and similar crude oil-based specialty items. The Plastics division is dedicated to the development, production, and sale of high-precision plastic parts tailored for industries like medical technology, automotive, and various other sectors. H&R's extensive product portfolio also encompasses petroleum jellies, different types of motor and process oils, cable filling compounds, ozone protection waxes, raw materials for the cosmetic and pharmaceutical sectors, mineral oils, and construction insulation materials. Founded in 1919 and headquartered in Salzbergen, Germany, the company transitioned its name to H&R GmbH & Co. KGaA in August 2016, having previously operated as H&R Aktiengesellschaft. It functions as a subsidiary of H&R Komplementär GmbH.
Related entities
Subsidiaries (6)
H&R ANZ PTY LTD
H&R Chemisch-Pharmazeutische Spezialitaten GmbH
H&R International GmbH
H&R Olwerke Schindler GmbH
H&R CHEMPHARM (UK) LIMITED
H&R South Africa (Pty) Ltd.
Key people
Joachim Girg
Chairman of the Supervisory Board · since 2012
Niels H. Hansen
Chairman of the Management Board, Chief Executive Officer · since 2016
Roland Chmiel
Independent Deputy Chairman of the Supervisory Board · since 2011
Detlev Woesten
Member of the Management Board · since 2016
Independent Member of the Supervisory Board · since 2019
Reinhold Grothus
Independent Member of the Supervisory Board, Employee Representative · since 2002
Sven Hansen
Member of the Supervisory Board · since 2016
Holger Hoff
Independent Member of the Supervisory Board, Employee Representative · since 2017
Harald Januszewski
Independent Member of the Supervisory Board, Employee Representative · since 2012
Hartmut Schuetter
Independent Member of the Supervisory Board · since 2013
Rolf Schwedhelm
Independent Member of the Supervisory Board · since 2011
Headquarters & legal address
Neuenkirchener Str. 8
Salzbergen, NI 48499
DE
Salzbergen, NI 48499
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||